electroCore (ECOR) Revenue Growth (3y) (2020 - 2026)
Powered by 
Analysis
electroCore (ECOR) Revenue Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 8.07% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 18.10% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 8.20% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 9.66% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 14.78% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 10.83% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 4.73% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 14.51% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 8.05% |
| 10 | electroCore | 87.36 Mn | 77.32 Mn | 8.18 Mn | 38.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.58% |
| Mar 31, 2026 | 51.07% |
| Dec 31, 2025 | 53.41% |
| Sep 30, 2025 | 63.83% |
| Jun 30, 2025 | 50.69% |
| Mar 31, 2025 | 52.38% |
| Dec 31, 2024 | 67.81% |
| Sep 30, 2024 | 63.96% |
| Jun 30, 2024 | 69.13% |
| Mar 31, 2024 | 65.35% |
| Dec 31, 2023 | 77.50% |
| Sep 30, 2023 | 60.97% |
| Jun 30, 2023 | 67.70% |
| Mar 31, 2023 | 55.89% |
| Dec 31, 2022 | 55.95% |
| Sep 30, 2022 | 42.49% |
| Jun 30, 2022 | 51.30% |
| Mar 31, 2022 | 66.75% |
| Dec 31, 2021 | 59.42% |
| Sep 30, 2021 | 114.36% |